ID   KLOT_RAT                Reviewed;        1014 AA.
AC   Q9Z2Y9;
DT   11-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   29-MAY-2024, entry version 159.
DE   RecName: Full=Klotho;
DE            EC=3.2.1.31;
DE   Contains:
DE     RecName: Full=Klotho peptide;
DE   Flags: Precursor;
GN   Name=Kl;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, INDUCTION, AND
RP   DEVELOPMENTAL STAGE.
RC   TISSUE=Lung;
RX   PubMed=9791011; DOI=10.1006/bbrc.1998.9576;
RA   Ohyama Y., Kurabayashi M., Masuda H., Nakamura T., Aihara Y., Kaname T.,
RA   Suga T., Arai M., Aizawa H., Matsumura Y., Kuro-o M., Nabeshima Y.,
RA   Nagai R.;
RT   "Molecular cloning of rat klotho cDNA: markedly decreased expression of
RT   klotho by acute inflammatory stress.";
RL   Biochem. Biophys. Res. Commun. 251:920-925(1998).
RN   [2]
RP   INDUCTION.
RX   PubMed=9731228; DOI=10.1006/bbrc.1998.9246;
RA   Aizawa H., Saito Y., Nakamura T., Inoue M., Imanari T., Ohyama Y.,
RA   Matsumura Y., Masuda H., Oba S., Mise N., Kimura K., Hasegawa A.,
RA   Kurabayashi M., Kuro-o M., Nabeshima Y., Nagai R.;
RT   "Downregulation of the Klotho gene in the kidney under sustained
RT   circulatory stress in rats.";
RL   Biochem. Biophys. Res. Commun. 249:865-871(1998).
RN   [3]
RP   TISSUE SPECIFICITY.
RX   PubMed=10631108; DOI=10.1006/bbrc.1999.2009;
RA   Kato Y., Arakawa E., Kinoshita S., Shirai A., Furuya A., Yamano K.,
RA   Nakamura K., Iida A., Anazawa H., Koh N., Iwano A., Imura A., Fujimori T.,
RA   Kuro-o M., Hanai N., Takeshige K., Nabeshima Y.;
RT   "Establishment of the anti-Klotho monoclonal antibodies and detection of
RT   Klotho protein in kidneys.";
RL   Biochem. Biophys. Res. Commun. 267:597-602(2000).
RN   [4]
RP   INDUCTION.
RX   PubMed=10892340; DOI=10.1007/s000180050038;
RA   Nagai R., Saito Y., Ohyama Y., Aizawa H., Suga T., Nakamura T.,
RA   Kurabayashi M., Kuroo M.;
RT   "Endothelial dysfunction in the klotho mouse and downregulation of klotho
RT   gene expression in various animal models of vascular and metabolic
RT   diseases.";
RL   Cell. Mol. Life Sci. 57:738-746(2000).
RN   [5]
RP   INDUCTION.
RX   PubMed=11967236; DOI=10.1161/01.hyp.0000013734.33441.ea;
RA   Mitani H., Ishizaka N., Aizawa T., Ohno M., Usui S., Suzuki T., Amaki T.,
RA   Mori I., Nakamura Y., Sato M., Nangaku M., Hirata Y., Nagai R.;
RT   "In vivo klotho gene transfer ameliorates angiotensin II-induced renal
RT   damage.";
RL   Hypertension 39:838-843(2002).
RN   [6]
RP   INDUCTION.
RX   PubMed=12965205; DOI=10.1016/s0014-5793(03)00894-9;
RA   Saito K., Ishizaka N., Mitani H., Ohno M., Nagai R.;
RT   "Iron chelation and a free radical scavenger suppress angiotensin II-
RT   induced downregulation of klotho, an anti-aging gene, in rat.";
RL   FEBS Lett. 551:58-62(2003).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=17992255; DOI=10.1172/jci32409;
RA   Ben-Dov I.Z., Galitzer H., Lavi-Moshayoff V., Goetz R., Kuro-o M.,
RA   Mohammadi M., Sirkis R., Naveh-Many T., Silver J.;
RT   "The parathyroid is a target organ for FGF23 in rats.";
RL   J. Clin. Invest. 117:4003-4008(2007).
CC   -!- FUNCTION: May have weak glycosidase activity towards glucuronylated
CC       steroids. However, it lacks essential active site Glu residues at
CC       positions 241 and 874, suggesting it may be inactive as a glycosidase
CC       in vivo. May be involved in the regulation of calcium and phosphorus
CC       homeostasis by inhibiting the synthesis of active vitamin D (By
CC       similarity). Essential factor for the specific interaction between
CC       FGF23 and FGFR1 (By similarity). {ECO:0000250}.
CC   -!- FUNCTION: The Klotho peptide generated by cleavage of the membrane-
CC       bound isoform may be an anti-aging circulating hormone which would
CC       extend life span by inhibiting insulin/IGF1 signaling. {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a beta-D-glucuronoside + H2O = an alcohol + D-glucuronate;
CC         Xref=Rhea:RHEA:17633, ChEBI:CHEBI:15377, ChEBI:CHEBI:30879,
CC         ChEBI:CHEBI:58720, ChEBI:CHEBI:83411; EC=3.2.1.31;
CC   -!- SUBUNIT: Homodimer. Interacts with FGF23 and FGFR1. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:O35082};
CC       Single-pass type I membrane protein {ECO:0000250|UniProtKB:O35082}.
CC       Apical cell membrane {ECO:0000250|UniProtKB:O35082}; Single-pass type I
CC       membrane protein {ECO:0000250|UniProtKB:O35082}. Note=Its shedding
CC       leads to a soluble peptide. {ECO:0000250|UniProtKB:O35082}.
CC   -!- SUBCELLULAR LOCATION: [Klotho peptide]: Secreted
CC       {ECO:0000250|UniProtKB:O35082}.
CC   -!- TISSUE SPECIFICITY: Present in cortical renal tubules and the
CC       parathyroid (at protein level). Strongly expressed in kidney. Expressed
CC       at low levels in brain, lung, intestine and ovaries.
CC       {ECO:0000269|PubMed:10631108, ECO:0000269|PubMed:17992255,
CC       ECO:0000269|PubMed:9791011}.
CC   -!- DEVELOPMENTAL STAGE: Expressed faintly from 18 dpc in the kidney.
CC       Expression increases in the kidney after 4 days of age.
CC       {ECO:0000269|PubMed:9791011}.
CC   -!- INDUCTION: Down-regulated by angiotensin II and iron overload (at
CC       protein level). Down-regulated by acute inflammatory stress, and in
CC       models for long-term hypertension, diabetes mellitus and chronic renal
CC       failure. {ECO:0000269|PubMed:10892340, ECO:0000269|PubMed:11967236,
CC       ECO:0000269|PubMed:12965205, ECO:0000269|PubMed:9731228,
CC       ECO:0000269|PubMed:9791011}.
CC   -!- DOMAIN: Contains 2 glycosyl hydrolase 1 regions. However, the first
CC       region lacks the essential Glu active site residue at position 241, and
CC       the second one lacks the essential Glu active site residue at position
CC       874.
CC   -!- PTM: N-glycosylated. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 1 family. Klotho
CC       subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=The thread of life - Issue
CC       65 of December 2005;
CC       URL="https://web.expasy.org/spotlight/back_issues/065";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB017820; BAA34740.1; -; mRNA.
DR   PIR; JE0333; JE0333.
DR   RefSeq; NP_112626.1; NM_031336.1.
DR   AlphaFoldDB; Q9Z2Y9; -.
DR   SMR; Q9Z2Y9; -.
DR   STRING; 10116.ENSRNOP00000001449; -.
DR   CAZy; GH1; Glycoside Hydrolase Family 1.
DR   GlyCosmos; Q9Z2Y9; 6 sites, No reported glycans.
DR   GlyGen; Q9Z2Y9; 6 sites.
DR   PhosphoSitePlus; Q9Z2Y9; -.
DR   PaxDb; 10116-ENSRNOP00000001449; -.
DR   ABCD; Q9Z2Y9; 1 sequenced antibody.
DR   Ensembl; ENSRNOT00000001449.5; ENSRNOP00000001449.3; ENSRNOG00000001092.6.
DR   GeneID; 83504; -.
DR   KEGG; rno:83504; -.
DR   UCSC; RGD:620396; rat.
DR   AGR; RGD:620396; -.
DR   CTD; 9365; -.
DR   RGD; 620396; Kl.
DR   eggNOG; KOG0626; Eukaryota.
DR   GeneTree; ENSGT00940000157614; -.
DR   HOGENOM; CLU_001859_5_2_1; -.
DR   InParanoid; Q9Z2Y9; -.
DR   OMA; HVSHFHF; -.
DR   OrthoDB; 3373839at2759; -.
DR   PhylomeDB; Q9Z2Y9; -.
DR   TreeFam; TF314803; -.
DR   Reactome; R-RNO-109704; PI3K Cascade.
DR   Reactome; R-RNO-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-RNO-190374; FGFR1c and Klotho ligand binding and activation.
DR   Reactome; R-RNO-5654219; Phospholipase C-mediated cascade: FGFR1.
DR   Reactome; R-RNO-5654687; Downstream signaling of activated FGFR1.
DR   Reactome; R-RNO-5654688; SHC-mediated cascade:FGFR1.
DR   Reactome; R-RNO-5654689; PI-3K cascade:FGFR1.
DR   Reactome; R-RNO-5654693; FRS-mediated FGFR1 signaling.
DR   Reactome; R-RNO-5654726; Negative regulation of FGFR1 signaling.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   PRO; PR:Q9Z2Y9; -.
DR   Proteomes; UP000002494; Chromosome 12.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0004566; F:beta-glucuronidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0017134; F:fibroblast growth factor binding; ISO:RGD.
DR   GO; GO:0005104; F:fibroblast growth factor receptor binding; ISO:RGD.
DR   GO; GO:0055074; P:calcium ion homeostasis; ISO:RGD.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro.
DR   GO; GO:0008340; P:determination of adult lifespan; ISO:RGD.
DR   GO; GO:0006112; P:energy reserve metabolic process; ISO:RGD.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0003085; P:negative regulation of systemic arterial blood pressure; IMP:RGD.
DR   GO; GO:0042421; P:norepinephrine biosynthetic process; IMP:RGD.
DR   GO; GO:0030501; P:positive regulation of bone mineralization; ISO:RGD.
DR   GO; GO:0090080; P:positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0014823; P:response to activity; IEP:RGD.
DR   GO; GO:1990776; P:response to angiotensin; IEP:RGD.
DR   GO; GO:0071774; P:response to fibroblast growth factor; IEP:RGD.
DR   GO; GO:0033280; P:response to vitamin D; IEP:RGD.
DR   Gene3D; 3.20.20.80; Glycosidases; 2.
DR   InterPro; IPR001360; Glyco_hydro_1.
DR   InterPro; IPR033132; Glyco_hydro_1_N_CS.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   PANTHER; PTHR10353; GLYCOSYL HYDROLASE; 1.
DR   PANTHER; PTHR10353:SF10; KLOTHO; 1.
DR   Pfam; PF00232; Glyco_hydro_1; 3.
DR   PRINTS; PR00131; GLHYDRLASE1.
DR   SUPFAM; SSF51445; (Trans)glycosidases; 2.
DR   PROSITE; PS00653; GLYCOSYL_HYDROL_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Glycoprotein; Glycosidase; Hydrolase; Membrane;
KW   Reference proteome; Repeat; Secreted; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..34
FT                   /evidence="ECO:0000255"
FT   CHAIN           35..1014
FT                   /note="Klotho"
FT                   /id="PRO_0000042249"
FT   CHAIN           35..?
FT                   /note="Klotho peptide"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000042250"
FT   TOPO_DOM        35..983
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        984..1004
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1005..1014
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          59..508
FT                   /note="Glycosyl hydrolase-1 1"
FT   REGION          517..955
FT                   /note="Glycosyl hydrolase-1 2"
FT   CARBOHYD        161
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        285
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        346
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        609
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        614
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        696
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   1014 AA;  116800 MW;  16F3B57581AC1DF0 CRC64;
     MPARAPPRRL PRLLLLRLLS LHLLLLTLRA RCLSAEPGQG AQTWARFARP PVPEASGLLH
     DTFPDGFLWA VGSAAYQTEG GWRQHGKGAS IWDTFTHHPR AIPEDSPIVM APSGAPLPPL
     PSTGDVASDS YNNVYRDTEG LRELGVTHYR FSISWARVLP NGTAGTPNRE GLRYYRRLLE
     RLRELGVQPV VTLYHWDLPQ RLQDTYGGWA NRALADHFRD YAELCFRHFG GQVKYWITID
     NPYVVAWHGY ATGRLAPGVR GSSRLGYLVA HNLLLAHAKV WRLYNTSFRP TQGGRVSIAL
     GSHWITPRRM TDYHIRECQK SLDFVLGWFA KPIFIDGDYP KSMKNNLSSL LPDFTESEKR
     FIRGTADFFA LSFGPTLSFQ LLDPSMKFRQ LESPSLRQLL SWIDLEYNHP QIFIVENGWF
     VSGTTRRDDA KYMYYLKKFI MESLKAIRLD GVDVIGYTAW SLMDGFEWHR GYSIRRGLFY
     VDFLSQDKEL LPKSSALFYQ KLIENNGFPP LPENQPLEGT FPCDFAWGVV DNYIQVDPTL
     SQFTDPNVYL WDVHHSKRLI KVDGVVAKKR KPYCVDFSAI RPQITLLREM RVTHFRFSLD
     WALILPLGNQ TQVNRTVLHF YRCMVSELVH ANITPVVALW QPATPHQGLP HALAKHGAWE
     NPHTALAFAD YANLCFEELG HWVKFWITIN EPNSRNMTYR AGHHLLKAHA LAWHLYDDKF
     RAAQKGKISI ALQVDWIEPA CPFSQKDKEV AERVLEFDVG WLAEPIFGSG DYPHVMREWL
     NQKNNFLLPY FTEDEKKLIR GSFDFLALSH YTTILVDWEK EDPIKYNDYL EVQEMTDITW
     LNSPNQVAVV PWGLRKALNW LRFKYGDLPM FVTANGIDDD PHAEQDSLRM YYIKNYVNEA
     LKAYVLDGIN LCGYFAYSLS DRSVPKSGFY RYAANQFEPK PSIKHYRKII DNNGFLGSGT
     LGRFCPEEYT VCTGCGFFQT RKSLLAFISF LVFAFVTSLA LIYYYSKKGR RRYK
//
